Ampersand Biomedicines Raises Series B Financing and Highlights Pipeline Advancements
March 19, 2025 07:00 ET
|
Ampersand Biomedicines
$65 million in Series B funding secured from investors, including founder Flagship Pioneering and Eli Lilly & Company Two lead programs in immuno-inflammation and immuno-oncology planned to enter...
CARGO Therapeutics Provides Corporate Update
March 18, 2025 16:05 ET
|
Cargo Therapeutics, Inc.
CARGO Therapeutics Provides Corporate Update
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 18, 2025 16:00 ET
|
Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on March 14, 2025 it granted stock options to purchase an aggregate of...
Data and Safety Monitoring Board Reviews Cohort 1 Safety Data and Approves Dosing Cohort 2 in the Clinical Trial of OCU200—a Novel Fusion Protein for Diabetic Macular Edema
March 18, 2025 08:02 ET
|
Ocugen
OCU200 has a very favorable safety and tolerability profileNo serious adverse events related to the study drug have been reportedDosing of the second cohort has been approved MALVERN, Pa., March 18,...
Angitia Biopharmaceuticals Presents Data from Phase 1/2 Study of AGA111 at 2025 AAOS Annual Meeting
March 18, 2025 07:00 ET
|
Angitia Incorporated Limited
WOODLAND HILLS, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Angitia Biopharmaceuticals, a global, clinical-stage biotechnology company focused on the discovery and development of innovative...
Allarity Therapeutics Announces Presentation of Phase 2 Clinical Data from Ongoing Trial in Advanced Ovarian Cancer Patients at the 2025 Annual Meeting for the Society of Gynecologic Oncology
March 17, 2025 08:00 ET
|
Allarity Therapeutics, Inc.
The Annual Meeting is the foremost educational and scientific event for gynecologic oncologistsStenoparib has shown clinical benefit in heavily pre-treated patients, including those with...
Cytokinetics Announces Five Presentations at the American College of Cardiology Annual Scientific Session & Expo
March 17, 2025 08:00 ET
|
Cytokinetics, Incorporated
New Analyses Related to Aficamten Expand on its Metabolism Pathways,Treatment Effect Associated with Combination Therapy with Disopyramideand Longer-Term Effect on Cardiac Structure and Function ...
Celex Oncology Announce Novel Mechanism in Cancer Care and Attendance at Bio-Europe Spring 2025
March 17, 2025 03:00 ET
|
Celex Oncology Innovations Limited
Celex Oncology, a UK biotechnology on the brink of launching the fourth revolution in cancer care, today announced their investigative model and treatment.
Global Reach for US Biotechs: Avance Clinical Secures MOUs with Four Premier Taiwanese Trial Sites
March 16, 2025 19:15 ET
|
Avance Clinical
Global Reach for US Biotechs: Avance Clinical Secures MOUs with Four Premier Taiwanese Trial Sites
aTyr Pharma Announces Fourth Quarter and Full Year 2024 Results and Provides Corporate Update
March 13, 2025 16:01 ET
|
aTyr Pharma, Inc.
aTyr Pharma Announces Fourth Quarter and Full Year 2024 Results and Provides Corporate Update